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Introduction
The well-being of farm animals is highly dependent 
on the prevention of disease outbreaks in husbandry. 
Numerous environmental stress factors favor the devel-
opment of pathogenic bacteria that interfere with the 
composition of commensal microbes in the gastroin-
testinal tract and induce diseases (Gaggìa et al. 2010). 
Many infections can be easily transferred from animals 
to humans by contaminated food of animal origin. One 
of the most common zoonosis is salmonellosis, which 
can cause a wide range of illnesses such as fever, sepsis, 
infections of tissues and inflammation of the gastro-
intestinal tract. It is often transferred to humans from 
infected poultry meat (Ryan et al. 2017).
Salmonella is a genus of the family Enterobacte­
riaceae and contains two species: S. enterica and S. bon­
gori. S. enterica is further subdivided into six subspe-
cies (I, S. enterica subsp. enterica, II, S. enterica subsp. 
salamae, IIIa, S. enterica subsp. arizonae, IIIb, S. enterica 
subsp. diarizonae, IV, S. enterica subsp. houtenae, and 
VI, S. enterica subsp. indica) (Brenner et al. 2000; Ryan 
et al. 2017). In the European Union, salmonellosis is the 
second most common foodborne disease and S. enterica 
is the most frequently reported pathogen (Kirk et al. 
2015; Bonardi et al. 2016; Shah et al. 2017; European 
Food Safety Authority (EFSA) and European Centre 
for Disease Prevention and Control (ECDC) 2018). The 
main source of Salmonella for humans is laying hens, 
followed by pigs, turkeys, and broilers (Kirk et al. 2015; 
Chousalkar and Gole 2016). Application of antibiotics to 
fight and prevent diseases is the most common practice 
but their overuse favors increasing number of antibiotic-
resistant strains of bacteria (Davies and Davies 2010; 
Gao et al. 2017). Concern about the development of 
such pathogens and the transfer of antibiotic resistance 
genes to human microbiota have led to considerable 
interest in search of novel methods to fight pathogens.
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A b s t r a c t
Probiotics are considered an alternative to antibiotics in the prevention and treatment of Salmonella diseases in poultry. However, to use 
probiotics as proposed above, it is necessary to evaluate their properties in detail and to select the most effective bacterial strains in the 
application targeted. In this study, probiotic properties of new Lactobacillus sp. strains were investigated and their antimicrobial activity 
against 125 environmental strains of Salmonella sp. was determined using the agar slab method. Furthermore, their survival in the pres-
ence of bile salts and at low pH, antibiotics susceptibility, aggregation and coaggregation ability, adherence to polystyrene and Caco-2 cells, 
and cytotoxicity were investigated. Each strain tested showed antagonistic activity against at least 96% of the environmental Salmonella sp. 
strains and thus representing a highly epidemiologically differentiated collection of poultry isolates. In addition, the probiotic properties 
of new Lactobacillus strains are promising. Therefore, all strains examined showed a high potential for use in poultry against salmonellosis.
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Probiotic bacteria application appears a promising 
alternative to antibiotics (Musikasang et al. 2009; Carter 
et al. 2017). Probiotics have the potential of competitive 
exclusion of pathogens and growth-promoting effects 
by supporting the absorption of certain essential nutri-
ents, thus increasing total body weight, feed intake, and 
feed conversion rate (Yeo et al. 2016; Angelakis 2017). 
Lactic acid bacteria (LAB) are the most common pro-
biotic bacteria used in food fermentation, and in taste 
and texture enhancement in fermented food products. 
They are proved to be safe for animals and humans 
(Vankerckhoven et al. 2008; Mokoena 2017). To con-
sider a strain as a potential probiotic, the strain has to 
possess certain health-promoting features such as the 
stimulation of host immune response or modulation 
of its microbiota (Romani Vestman et al. 2013). How-
ever, in the development of a probiotic product, also 
the safety, functional and technological aspects need 
to be considered (Hütt et al. 2006; Belicová et al. 2013). 
Probiotic has to withstand harsh gastrointestinal tract 
conditions (such as low pH, and presence of bile salts) 
and be able to adhere to intestinal epithelial cells (Kos 
et al. 2003; Kaushik et al. 2009; Tinrat et al. 2011).
The recent studies demonstrated that the application 
of probiotic cultures successfully reduced Salmonella sp. 
in farm animals. In 2003, La Ragione and Woodward 
described the controlling of Salmonella Enteritidis in 
young chickens by Bacillus subtilis, and in 2017 Carter 
et al. used a combination of Lactobacillus salivarius and 
Enterococcus faecium to treat the same pathogen also 
in poultry (La Ragione and Woodward 2003; Carter 
et al. 2017). Some other publications report the results 
of application of commercially available anti-Salmo­
nella probiotic products like FloraMax-B11® contain-
ing Lacto bacillus salivarius and Pediococcus parvulus 
(Prado-Rebolledo et al. 2017) or FM-B11™ containing 
11  Lactobacillus strains (three of L. bulgaricus, three 
of L. fermentum, two of L. casei, two of L. cellobiosus, 
and one of L. helveticus) (Higgins et al. 2008; Vicente 
et al. 2008). However, there is still a need for novel 
strains of probiotics with a wide spectrum of activity 
that can be used as an antibacterial agent in farm ani-
mals (Reid 2017).
The aim of this research was to investigate the 
pro bio tic properties of new Lactobacillus sp. strains: 
L. rhamnosus LOCK 1131, L. casei LOCK 1132, and 
L. paracasei LOCK 1133, which are considered as a feed 
additive for prevention and treatment Salmonella in 
poultry. We investigated their survival in bile salts and 
low pH, antibiotic resistance, aggregation properties, 
and adherence to polystyrene and Caco-2 cells. The 
safety of the application of the strains was verified by 
the cytotoxicity test, and their effec tivity was assessed 
by the competition assay and by the measurement of 
their antagonistic activity towards Salmonella strains.
Experimental
Materials and Methods
Bacterial strains. Three strains of Lactobacillus sp.: 
L. rhamnosus LOCK 1131, L. casei LOCK 1132, and 
L. para casei LOCK 1133 were isolated. The first two 
strains were isolated from chicks ileal content, while the 
third strain derived from the domestic fermented cab-
bage. The strain were deposited in the collection of the 
Institute of Fermentation Technology and Microbiology 
(LOCK 105), Lodz University of Technology, Poland.
Additionally, 126 Salmonella sp. strains were used: 
three reference strains from American Type Culture 
Collection (ATCC, USA) and 123 environmental 
strains from the collection of Proteon Pharmaceuticals 
SA (Table III). These strains are the epidemiologically 
representative group of strains isolated from poultry 
in 2009–2016 from different geographical regions of 
Poland. Strains were confirmed as genetically different, 
as described by Zaczek et al. in 2015.
Lactobacillus sp. strains were cultivated in De Man, 
Rogosa and Sharpe (MRS) broth (Merck-Millipore, 
Darmstadt, Germany). Salmonella sp. strains were culti-
vated in nutrient broth with glucose (Merck-Millipore, 
Darmstadt, Germany) or LB broth (BIOCORP, Warsaw, 
Poland). The strains were stored at –80°C in the broth 
supplemented with 25% glycerol. Strains were grown 
at 37°C. Stock cultures were stored for 24 h at 4–10°C.
Survival of lactobacilli in the presence of bile salts. 
As the concentration of bile salts in the small intes-
tine ranges from 0.2 to 2% (Kristoffersen et al. 2007), 
the ability of LAB strains to survive in the presence of 
bile salts (1  and 2%) was evaluated during and after 
their exposure for 1–4 h (as the food passage through 
small intestine takes up to 5 h). Tubes containing 30 ml 
MRS broth were inoculated with bacterial stock cul-
tures (3%, v/v) and incubated for 24 h at 37°C. After 
incubation, 1 ml aliquots were taken, serially diluted 
and plated on MRS agar in order to enumerate the 
initial bacterial population (at 0 h). Meanwhile, bac-
teria grown in MRS broth were centrifuged (3852 × g, 
10 min, 4°C), washed with sterile phosphate buffer 
saline (PBS, pH  7.2, Sigma-Aldrich, St. Louis, MO, 
USA), divided into three portions, and finally sus-
pended in distilled water containing 1% and 2% of bile 
salts (Sigma-Aldrich, St. Louis, MO, USA) or in dis-
tilled water without bile salts (control), respectively. The 
suspensions were then incubated aerobically at 37°C. 
After 1, 2, and 4 h, 1 ml aliquots were taken from each 
sample, serially diluted in sterile saline, and plated on 
MRS agar for the enumeration of total viable counts. 
Plates were incubated for 48 h at 37°C, colonies were 
counted and the bacterial population was calculated 
for each measurement point.
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Survival of lactobacilli at low pH. The ability of 
LAB strains to survive at low pH (pH 2.0 and 3.0 – sim-
ilar to pH of gastric juice, which is 1.5–3.5) was inves-
tigated during 1–4 h (as the food passage through the 
stomach is up to 5 h). Tubes containing 30 ml of MRS 
broth were inoculated with bacterial stock cultures (3%, 
v/v) and incubated for 24 h at 37°C. After incubation, 
1 ml aliquots were taken, serially diluted, and plated 
on MRS agar in order to enumerate the initial bacte-
rial population (at 0 h). Meanwhile, bacteria grown in 
MRS broth were centrifuged (3852 × g, 10 min, 4°C), 
washed with sterile PBS, divided into three portions 
and suspended in sterile saline, adjusted to pH 2.0 or 
3.0 respectively (with 0.1 M HCl), and the sterile saline 
with unchanged pH that was included as a control. The 
suspensions were then incubated aerobically at 37°C. 
After 1, 2, and 4 h 1 ml aliquots were taken from each 
sample, serially diluted in sterile saline, and plated on 
MRS agar. After incubation of plates for 48 h at 37°C, 
the viable counts were determined.
Testing of susceptibility to antibiotics. The anti-
biotic resistance of LAB strains was screened by the 
agar disc diffusion method using discs impregnated 
with specified concentrations of antibiotics (Oxoid, 
Dardilly, France). A total of six antibiotics were tested: 
penicillin G (1 unit), kanamycin (30 μg), tetracycline 
(30 μg), erythromycin (30 μg), doxycycline (30 μg), and 
amoxicillin (25 μg). These were commercial antibio-
tics and their standard doses were commonly used for 
testing of probiotic bacteria. Antibiotics are mainly 
absorbed in the ileum and their therapeutic dose, 
which reaches the colon is lower than the initial dose 
(Moubareck et al. 2005). Briefly, 100 μl of the 24-hour 
culture of LAB was spread on MRS agar plates using 
a sterile L-shaped bacterial spreader and antibiotic discs 
were placed aseptically on the surface of the agar. Each 
antibiotic was tested in triplicate. Plates were incubated 
for 24 h at 37°C and the diameters of the inhibition 
zones were measured with a ruler. The results (aver-
age of three readings) were interpreted according to 
the standards defined by the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST 2012).
Aggregation and coaggregation assays. Aggrega-
tion assay was performed as described by Kos et al. 
(2003) and Jankovic et al. (2012) with some modifica-
tions. LAB grown for 24 h in a liquid MRS were har-
vested by centrifugation (3852 × g, 10 min), washed 
once and re-suspended in PBS to give a final optical 
density of 1.0 at 600 nm, as measured by the spectro-
photometer (Beckman DU 640, USA). For the auto-
aggre gation assay, the cell suspension of each bacte-
rial strain was vortexed for 10 s and incubated at room 
temperature without agitation. After 24 h, 100 μl of the 
suspension (the upper part) was transferred to another 
tube and the absorbance was measured at 600 nm. The 
autoaggregation percentage was determined using 
equation 1, as follows:
(1)
where At represents the absorbance at time t = 24 h, and 
A0 the absorbance at time t = 0 h.
The coaggregation was measured for LAB with 
reference to pathogenic strains of Salmonella sp. For 
the coaggregation assay, LAB and Salmonella sp. cell 
suspensions were prepared in the same way as that 
for the autoaggregation assay, but Salmonella sp. were 
cultivated in nutrient broth medium. Equal volumes 
of LAB and Salmonella sp. suspensions were mixed by 
vortexing for 10 s. As control tubes, samples from the 
autoaggregation assay containing aliquots of single bac-
terial suspension were used. The absorbance of suspen-
sions was measured after 24 h, as described above. The 
percentage of coaggregation was calculated according 
to equation 2 (Handley et al. 1987), as follows:
(2)
where Ax and Ay represent absorbance of each of the 
two strains in the control tubes and Ax+y absorbance 
of their mixture. Each experiment was performed in 
triplicate.
Adherence to polystyrene. The adherence was 
determined according to the method described by 
Zeraik and Nitschke (2012) with some modifications 
(Aleksandrzak-Piekarczyk et al. 2016). Bacterial sus-
pensions in PBS were prepared the same way as for the 
autoaggregation assay, then added into 96-well polysty-
rene plate (in eight repeats each), and incubated for 2 h 
at 37°C. Non-adherent bacteria were slightly washed 
away with water, and adherent bacteria were fixed with 
80% methanol (15 min) and stained with 0.1% crystal 
violet (15 min, 120 rpm). Next, the wells were washed 
out with water and incubated with 33% glacial acetic 
acid (15 min, 120 rpm). The absorbance was measured 
at 630 nm with a microplate reader (Tristar2 LB 942, 
Berthold Technologies). To calculate the adhesion ratio 
of bacteria to polystyrene, the value of absorbance of 
bacteria was divided by the absorbance of the control 
sample (absorbance read in polystyrene wells only).
Adherence to human colon adenocarcinoma cells 
(Caco-2). The adherence of probiotic bacteria to colon 
cells of the gastrointestinal tract is a clue process for 
bacteria to survive and colonize this ecosystem as the 
adherence prevents probiotic cells from being washed 
out, and enables temporary colonization of the colon 
(Nowak and Motyl 2017). The adherence assay of Lac­
tobacillus sp. strains to human colon adenocarcinoma 
cell line (Caco-2) was described previously (Nowak 
Autoagregation (%) = 1 –          × 100
At
A0
Coaggregation (%) =                                  × 100
(Ax + Ay) / 2 – Ax + y
(Ax + Ay) / 2
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as described by Repetto et al. (2008) and Borowiec et al. 
(2016) with some modifications. LAB supernatants 
were prepared from overnight culture by centrifugation 
(3852 × g, 10 min), and sterilization through a 0.22 µm 
filter. Caco-2 cells were seeded in 96-well plates in 
a concentration of 104 cells per well and exposed to LAB 
supernatants at different concentrations for 72 hours at 
37°C in a humidified atmosphere of 5% CO2. The LAB 
supernatants were diluted as follows: 1, 1:2, 1:4, 1:8, 
1:16, and the medium for cell culture was used as a con-
trol. After incubation, cells were washed with PBS and 
incubated with 50 g/ml neutral red in Hanks’ Balanced 
Salt Solution for 3 h, then washed with PBS again. Cell-
bound dye was extracted with a  solution containing 
50% ethanol and 1% acetic acid by gentle shaking for 
10 min. Absorbance at 550 nm was read at the Sunrise 
microplate reader (Tecan, Männedorf, Switzerland).
Antagonistic activity of lactobacilli towards ref-
erence and environmental strains of Salmonella sp. 
The inter-strain antagonism was investigated using the 
agar slab method (Strus 1998; Klewicka and Libudzisz 
2004). To test the activity of LAB against Salmonella 
strains, strains of Lactobacillus sp. (at the density of 
108 CFU/ml) were introduced into MRS agar medium 
and poured onto Petri dishes. Then, LAB strains were 
incubated at 37°C for 24 h. In the meantime Salmonella 
sp. stock cultures were prepared and 100 μl of each cul-
ture was spread on NB or LB agar plates using a sterile 
L-shaped bacterial spreader. Next, slabs around 9 mm 
in diameter (in three repeats) were cut out from solidi-
fied MRS medium overgrown with LAB and put on the 
prepared agar broth containing Salmonella sp. strains 
(106 CFU/ml). The dishes were incubated at 37°C for 
18 h. Following the incubation, the diameter of the test 
strain growth inhibition zone was measured, the slab 
diameter was subtracted, and the result was presented 
in millimeters. To compare the antagonistic activity 
of the strains of LAB against the Salmonella cultures, 
the following criteria were adopted: the growth inhibi-
tion diameter above 11 mm – strong inhibition (+++), 
6–10 mm – moderate inhibition (++), 1–5.9 mm – weak 
inhibition (+), 0 mm – no inhibition (–). The index of 
total antagonistic activity (IAA) was calculated as a sum 
of scores determined by the diameter of growth inhi-
bition of bacteria (+++ 3 points; ++ 2 points; + 1 point; 
– 0 points), (Klewicka and Libudzisz 2004).
Statistical analysis. Statistical analysis was per-
formed using Statistica (ver. 13.1) as the statistical 
program. 1-way ANOVA followed by Tukey’s post hoc 
test was performed for comparison of growth inhibition 
zone in the assay of antagonistic activity of Lactoba­
cillus sp. strains against Salmonella sp. 1-way ANOVA 
followed by Dunnett’s post hoc test was performed for 
comparison of cytotoxic activity towards Caco-2 cells. 
Significant differences were declared at p < 0.05.
and Motyl 2017). Briefly, Caco-2 cells were seeded in 
24-well tissue culture plates (Becton, Dickinson and 
Co., Franklin Lakes, NJ, USA) at a concentration of 
2.5 × 105 cells per well to obtain confluent monolay-
ers. Before the experiment, LAB strains were grown 
in MRS broth for 24 h at 37°C. After growth, bacteria 
were harvested by centrifugation (3852 × g, 10 min), 
washed with sterile PBS and re-suspended in fresh 
Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-
Aldrich, St. Louis, MO, USA) without antibiotics and 
deposited on Caco-2 cells monolayer at the density of 
2.8 × 108 CFU/ml. To provide each time the same den-
sity of the initial population of bacteria added to wells, 
the relationship between the number of bacteria of each 
LAB strain and its absorbance (λ = 540 nm) was drawn 
as a curve. Each strain was tested in triplicate. The plate 
was incubated for 2 h at 37°C in a 5% CO2 atmosphere. 
After incubation, the unbound bacteria were removed. 
They were aspirated and wells were slightly washed 
with sterile PBS. Then wells were treated with 1% 
trypsin-EDTA (Sigma-Aldrich, St. Louis, MO, USA) 
for 5 min at 37°C to detach the cells and, additionally, 
the wells were scraped with a cell scraper. Subsequently, 
Caco-2 cells were harvested by centrifugation (3852 × g, 
10 min), and treated with 0.1% Triton X-100 (Sigma-
Aldrich, St. Louis, MO, USA) for 5 min for lysis. The 
adherent bacterial cells were enumerated by the pour 
plating serial dilution method in MRS agar and the 
plates were incubated for 48 h at 37°C. The adherence 
(%) was expressed as a ratio of the number of adherent 
bacteria to the number of total bacteria added initially 
to each well (an adherence index).
Competition assay. The adherence assay to Caco-2 
cells of Lactobacillus sp. strains in a competition test 
with pathogens was described previously (Nowak 
and Motyl 2017). In brief, the reference Salmonella 
sp. strains (108 CFU/ml) were added to the wells with 
Caco-2 cells monolayer as a single strains for individual 
adherence assay or in conjunction with probiotic strains 
(1:1) and then incubated at 37°C in 5% CO2 (Galaxy 
48S, New Brunswick, United Kingdom) for 2 h. For 
each strain, the adherent bacteria were enumerated by 
plate counting with SS Agar medium (Merck-Millipore, 
Darmstadt, Germany) and were incubated in aerobic 
conditions at 37°C for 48 h. The inhibition rate [%] was 
calculated according to the equation 3, this represented 
a percentage reduction in adherent pathogens in the 
presence of a probiotic (as compared to the results for 
the pathogen alone):
(3)
Cytotoxicity. Cytotoxicity of the probiotics tested 
was measured by the neutral red uptake (NRU) assay 
Inhibition rate (%) =                                                                         – 100
Log adherence of the tested sample × 100
Log adherence of the control
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Results
The resistance of LAB to bile salts. The survival 
of the LAB strains examined in bile salts at concentra-
tions of 1% and 2% is presented in Fig. 1. The highest 
decrease in the cell number was observed for L. rham­
nosus LOCK 1131 after incubation in the presence of 
1% of bile salt, with the highest drop occurring just 
after 1 h of incubation (–6 log). The increased bile salts 
tolerance was observed for 2% bile salts concentration 
for this bacteria. L. casei LOCK 1132 and L. paracasei 
LOCK 1133 demonstrated a relatively high survival 
rate even after 4 h incubation at 1% and 2% of bile salts 
(–3 log for L. casei and –3.9 log for L. paracasei). The 
decrease in the bacterial number at 1% and 2% of bile 
salts was statistically significant (p < 0.05) for all strains 
even after an hour incubation.
Resistance of LAB to low pH. The resistance of lac-
tic acid bacteria to pH 2.0 and pH 3.0 is shown in Fig. 2. 
L. rhamnosus LOCK 1131 and L. casei LOCK 1132 
demonstrated very high survival at both pH values, as 
almost no decrease in viability was observed after 4 h of 
incubation, when compared to the control sample with 
physiological saline. However, the viability of L. paraca­
sei LOCK 1133 at more acidic pH (pH 2.0) decreased 
significantly (p < 0.05) from 8.8 ± 0.04 log CFU/ml to 
approx. 2.9 ± 0.1 log CFU/ml after 4 h, while in less 
acidic environment (pH 3.0) the number of viable cells 
remained higher (4.4 ± 0.3 log CFU/ml).
Antibiotic susceptibility. The results of antibiotic 
resistance testing of LAB strains are collected in Table I. 
All strains were resistant to amoxicillin (25 μg) and kan-
amycin (30 μg). Besides, all strains were susceptible to 
penicillin G (1 unit), tetracycline (30 μg), erythromycin 
(30 μg), and doxycycline (30 μg).
Aggregation and coaggregation with Salmonella 
sp. All LAB strains showed high autoaggregation ability 
with the autoaggregation rate (Table II) ranging from 
93.5% ± 1.2 (for L. paracasei LOCK 1133) to 98.2% ± 3.6 
(for L. casei LOCK 1132) observed after 24 h.
The coaggregation of LAB strains with three refer-
ence Salmonella sp. strains was also explored. L. rham­
nosus LOCK 1131 exhibited the highest coaggregation 
with S. Typhimurium ATCC 13311 and S. Typhimurium 
Fig. 1. The survival of lactic acid bacteria at 1% and 2% bile salts.
Fig. 2. The resistance of LAB to low pH.
Kowalska J.D. et al. 110
ATCC 14028 (Table II), while L. casei LOCK 1132 with 
S. Typhimurium ATCC 13311. L. paracasei LOCK 1133 
demonstrated moderate coaggregation with S. Enteri-
tidis ATCC 13076 and S. Typhimurium ATCC 14028, 
but weak with S. Typhimurium ATCC 13311.
Adherence to polystyrene and Caco-2 cells. The 
adherence to polystyrene surface and Caco-2 cells was 
evaluated for all LAB strains. The results are collected 
in Table II. All strains demonstrated weak adherence 
properties with adherence ranging from 1.18 ± 0.02 
to 1.22 ± 0.02. All strains strongly adhered to Caco-2 
cells. The highest level of adherence was observed for 
L. casei LOCK 1132 (98.0%). However, L. rhamnosus 
LOCK 1131 also exhibited strong adherence to intes-
tinal epithelial cells (89.8%). L. paracasei LOCK 1133 
had a statistically significantly lower adherence index 
than other strains (78.9%).
Antagonistic activity of LAB in competition assay 
– adherence to Caco-2 cells. In the competition test, 
the antagonistic activity of LAB on the adherence of 
Salmonella sp. ATCC strains to adenocarcinoma cells 
Caco-2 was tested. Only L. casei LOCK 1132 showed 
good efficiency in inhibition of two tested Salmonella 
strains: S. Enteritidis ATCC 13076 and S. Typhimurium 
ATCC 14028, up to 3.4% and 7.9%, respectively (Fig. 3). 
L. rhamnosus LOCK 1131 weakly reduced adherence 
only of S. Typhimurium ATCC 13311 (in 1%), while 
L. paracasei LOCK 1133 stimulated adherence of all 
tested Salmonella sp. strains (from approx. 5 to 10%).
Cytotoxicity assay of LAB metabolic products. 
To assess cytotoxic effect of LAB strains, the effects of 
bacterial supernatants from LAB liquid cultures were 
examined in the comparison with the bacterial medium 
used for cell culture. The medium itself, regardless of 
the dilution factor, induced significant cytotoxic activ-
ity (p < 0.05 for dilutions between 1:1 and 1:8). There 
were no statistically significant differences between 
LAB supernatants and the medium itself for any strain 
or dilution. The results are presented as average from 
four experiments. Fig. 4 presents the cytotoxic effect of 
LAB supernatants. The obtained results indicate very 
low cytotoxicity towards Caco-2 cells of substances 
secreted into the medium by bacteria in the range of 
tested dilutions.
Antagonistic activity of LAB against Salmonella 
sp. The antagonism of LAB was investigated against 
126 Salmonella sp. strains, including three reference 
strains from ATCC and 123 environmental Salmonella 
Enteritidis. All strains of LAB demonstrated strong 
antagonistic activity towards all tested Salmonella sp. 
strains (Table III).
L. paracasei LOCK 1133 displayed the largest growth 
inhibition zone of all LAB strains tested for the highest 
number of Salmonella sp. strains; while, L. rhamnosus 
L. rhamnosus 27 ± 2.5 0 34 ± 1.0 33 ± 2.5 32 ± 2.0 21 ± 2.1
LOCK 1131 (S) (R) (S) (S) (S) (R)
L. casei 28 ± 2.5 0 30 ± 0.6 34 ± 1.5 33 ± 1.0 24 ± 0.6
LOCK 1132 (S) (R) (S) (S) (S) (IR)
L. paracasei 27 ± 6.4 0 25 ± 1.5 25 ± 0.0 30 ± 0.6 21 ± 1.0
LOCK 1133 (S) (R) (S) (S) (S) (R)
Table I
Antibiotic resistance of Lactobacillus strains.
S: susceptible; R: resistant; IR: intermediate resistant
PEN: Penicillin G (1 unit); KAN: Kanamycin (30 μg); TET: Tetracycline (30 μg);
ERY: Erythromycin (30 μg); DOX: Doxycycline (30 μg); AMX: Amoxicillin (25 μg)
Antibiotic inhibition zone diameter
[mm ± SD]
PEN KAN AMXDOXERYTET
L. rhamnosus LOCK 1131 96.1% ± 1.2% 14.8% ± 0.01% 84.2% ± 0.01% 51.8% ± 0.03% 1.18 ± 0.02 8.5 7.6 ± 1.1 89.8%
L. casei LOCK 1132 98.2% ± 3.6% 26.1% ± 0.01% 58.5% ± 0.01% –11.1%± 0.01% 1.22 ± 0.02 8.5 8.3 ± 0.5 98.0%
L. paracasei LOCK 1133 93.5% ± 0.9% 41.8% ± 3.4% 17.8% ± 3.3% 43.7% ± 2.7% 1.20 ± 0.07 8.0 6.3 ± 0.1 78.9%
Table II
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LOCK 1131 for the lowest number of strains. The calcu-
lated IAA values were similar for all three LAB strains 
with the highest value reported for L. rhamnosus LOCK 
1131 (185 points) and lowest for L. casei LOCK 1132 
(178 points) (Fig. 5).
Discussion
The increasing number of evidence demonstrates 
that probiotics are effective in the prevention and treat-
ment of bacterial diseases in animals. Due to limita-
tions in the application of antibiotics, probiotics may 
be a promising alternative. It holds especially in case 
of Salmonella, the second most widespread foodborne 
pathogen (European Food Safety Authority (EFSA) and 
European Centre for Disease Prevention and Control 
Fig. 3. Adherence of Salmonella sp. strains to adenocarcinoma cells Caco-2 in the presence of lactic acid bacteria
 presented as stimulation/inhibition rate (%).
Fig. 4. Cytotoxic effect of probiotics’ supernatants on Caco-2 cells in the range of tested dilutions presented as % of control.
Fig. 5. Total antagonistic activity index (IAA)
of lactic acid bacteria.
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S. Typhimurium ATCC 13311  +++ +++ +++
S. Typhimurium ATCC 14028  +++ +++ +++
S. Enteritidis ATCC 13076  +++ +++ +++
S. Enteritidis 1067/S/09 K-2 2009 + a + a +++ b
S. Enteritidis 848/S/09 2009 ++ a + b ++ a
S. Enteritidis Ferma ‘K’ K-9 2010 + a + a ++ b
S. Enteritidis Woź K-7 2010 + a ++ a ++ b
S. Enteritidis Ferma ‘K’ K-10 2010 ++ a + b ++ a
S. Enteritidis Ferma ‘K’ K-11 2010 ++ a + b ++ a
S. Enteritidis Ferma ‘K’ K-12 2010 + a + b + a
S. Enteritidis Ferma ‘K’ K-3 2010 + a ++ b + a
S. Enteritidis Ferma ‘K’ K-4 2010 + a ++ b + a
S. Enteritidis Ferma ‘K’ K-6 2010 + a + b + a
S. Enteritidis Ferma ‘K’ K-14 2010 + b + a ++ a
S. Enteritidis Ferma ‘K’ K-18 2010 ++ a + ab + b
S. Enteritidis Pac K-piętro 2010 + ab + a + b
S. Enteritidis Woź K-6 2010 + + +
S. Enteritidis Woź K-9 2010 ++ a + ab + b
S. Enteritidis 64/S/10 2010 + + +
S. Enteritidis 249 2010 + + +
S. Enteritidis 517/S/09 2009 ++ a + ab + b
S. Enteritidis 571/S/09 2009 + a + b ++ c
S. Enteritidis 833/S/09 2009 + + ++
S. Enteritidis 838/S/09 2009 ++ b + a + a
S. Enteritidis 838/S/09 B 2009 + + ++
S. Enteritidis 847/S/09 2009 + a + a - b
S. Enteritidis 865/S/09 2009 + + +
S. Enteritidis 866/S/09 2009 + a - b + a
S. Enteritidis 945/S/09 2009 ++ b + a - a
S. Enteritidis 975/S/09 2009 + + +
S. Enteritidis 1013/S/09 K-4 2009 + a ++ b + a
S. Enteritidis 1014/S/09 K-1 2009 + b ++ a + a
S. Enteritidis 1021/S/09 2009 ++ b + a + a
S. Enteritidis 1022/S/09 K-9 2009 ++ a ++ a + b
S. Enteritidis 1542/S/09 NWJ 2009 + ab + a + b
S. Enteritidis 1044/S/09 K-2 2009 + a - b + a
S. Enteritidis 1445/S/09 K-46 2009 + + +
S. Enteritidis 1446/S/09 K-31 2009 ++ b + a + a
S. Enteritidis 1465/S/09 MEK 2009 + a - b + a
S. Enteritidis 1515/S/09 2009 + a + ab + b
S. Enteritidis 1535/S/09 NWJ 2009 + b + a + a
S. Enteritidis 1714/09 2009 + + +
S. Enteritidis 2050/S/09 2009 + a + ab + b
S. Enteritidis 1085/S/09 MEK 2009 ++ a ++ b + c
S. Enteritidis 1231/S/09 2009 + + +
S. Enteritidis 1206/S/09 MEK 2009 ++ a + b - c
Table III
Antagonistic activity of Lactobacillus sp. strains against Salmonella sp. (type of inhibition:
+++ strong; ++ moderate; + weak; – no inhibition).
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S. Enteritidis 1171/S/09 2009 - a ++ b + c
S. Enteritidis 1257/S/09 K7 2009 ++ a ++ b + c
S. Enteritidis 1250/S/09 2009 + a ++ b + a
S. Enteritidis 1143/S/09 2009 + a ++ b ++ ab
S. Enteritidis 1422/S/09 MEK 2009 + a ++ b + c
S. Enteritidis 1106/S/09 K-1 2009 + a + a ++ b
S. Enteritidis 1061/S/09/K-5 2009 ++ b ++ a ++ a
S. Enteritidis 1067/S/09 K-3 2009 + ++ +
S. Enteritidis 1573/S/09 NWJ 2009 ++ a ++ b ++ c
S. Enteritidis 1192/S/09 K-8 2009 ++ ab ++ a + b
S. Enteritidis 1047/S/09 K-1 2009 ++ a ++ a + b
S. Enteritidis 1545/S/09 MEK 2009 + ab ++ a + b
S. Enteritidis 1048/S/09 K-8 2009 + + +
S. Enteritidis 1572/S/09 NWJ 2009 ++ ab ++ a ++ b
S. Enteritidis 002PP2014 2014 + a ++ ab ++ b
S. Enteritidis 004PP2014 2014 + a ++ b ++ b
S. Enteritidis 005PP2014 2014 ++ a + b + c
S. Enteritidis 001PP2014 2014 ++ ++ ++
S. Enteritidis 006PP2014 2014 + + +
S. Enteritidis 007PP2014 2014 ++ a + b ++ a
S. Enteritidis 2149/09 2009 ++ a + b ++ a
S. Enteritidis 2619/S/10 2010 + b + a + a
S. Enteritidis 003PP2014 2014 ++ a + a ++ b
S. Enteritidis 008PP2014 2014 + b ++ a ++ a
S. Enteritidis 009PP2014 2014 + a + b + a
S. Enteritidis 010PP2014 2014 + a + b + a
S. Enteritidis 12617/2/S 2014 + a + a ++ b
S. Enteritidis 12633 2014 + + +
S. Enteritidis 12961/1 2014 + b ++ a ++ a
S. Enteritidis 13001 2014 + a ++ ab ++ b
S. Enteritidis 011PP2014 2014 ++ a ++ b ++ ab
S. Enteritidis 012PP2014 2014 + a + a ++ b
S. Enteritidis 014PP2014 2014 + a + a ++ b
S. Enteritidis 015PP2014 2014 + a + a ++ b
S. Enteritidis 016PP2015 2015 + a + a ++ b
S. Enteritidis 017PP2015 2015 ++ a + b + ab
S. Enteritidis 018PP2015 2015 ++ ++ ++
S. Enteritidis 019PP2015 2015 ++ a + b + c
S. Enteritidis 020PP2016 2016 + + +
S. Enteritidis 021PP2016 2016 ++ ++ ++
S. Enteritidis 022PP2016 2016 + a + b ++ a
S. Enteritidis 023PP2016 2016 + ++ +
S. Enteritidis 024PP2016 2016 + a + b ++ c
S. Enteritidis 025PP2016 2016 + + +
S. Enteritidis 026PP2016 2016 ++ a ++ ab + b
S. Enteritidis 027PP2016 2016 ++ a + b + c
S. Enteritidis 028PP2016 2016 + a - b + c
Table III
Continued
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(ECDC) 2018), which is very difficult to control in 
poultry farming; thus, prevention and control strategies 
in commercial livestock are essential. When treatment 
is necessary it may occur that the causative strains can 
be resistant to most of the antibiotics.
Recent methods for Salmonella treatment, apart 
from antibiotics, include also application of probiot-
ics (Patterson and Burkholder 2003), bacteriophages 
(Fiorentin et al. 2005; Toro et al. 2005; Kim et al. 2014), 
organic acids, plants extracts, and essential oils (Tellez 
et al. 2012). There is also evidence that ammonia at 
high pH is effective against Salmonella in poultry farm-
ing (Koziel et al. 2017). Promising results have been 
observed when treatments with bacteriophages and 
competitive exclusion products were applied simulta-
neously (Toro et al. 2005; Borie et al. 2009).
Therefore, lactic acid bacteria strains that reduce 
or even eliminate Salmonella in animal husbandry are 
highly desired. In this study, we examined three new 
Lactobacillus sp. strains selected from ileal content 
(L. rhamnosus LOCK 1131, L. casei LOCK 1132) and 
domestic fermented cabbage (L. paracasei LOCK 1133). 
a, b, c Different superscripts in the same row denote statistically significant differences in antagonistic activity
 of different Lactobacillus strains (p ≤ 0.05).
Table III
Continued







S. Enteritidis 029PP2016 2016 + a + b + a
S. Enteritidis 030PP2016 2016 + a - b + a
S. Enteritidis 031PP2016 2016 + + +
S. Enteritidis 032PP2016 2016 ++ a ++ b ++ c
S. Enteritidis 033PP2016 2016 ++ ++ ++
S. Enteritidis 034PP2016 2016 + + +
S. Enteritidis 035PP2016 2016 ++ a ++ b + c
S. Enteritidis 036PP2016 2016 ++ ++ ++
S. Enteritidis 037PP2016 2016 + a ++ b + a
S. Enteritidis 038PP2016 2016 ++ a + b ++ a
S. Enteritidis 039PP2016 2016 ++ ++ +
S. Enteritidis 040PP2016 2016 ++ a ++ b ++ ab
S. Enteritidis 041PP2016 2016 ++ b ++ a ++ a
S. Enteritidis 042PP2016 2016 ++ ++ ++
S. Enteritidis 043PP2016 2016 + a + a ++ b
S. Enteritidis 044PP2016 2016 ++ a +++ b ++ a
S. Enteritidis 045PP2016 2016 ++ +++ ++
S. Enteritidis 046PP2016 2016 + ++ +
S. Enteritidis 047PP2016 2016 ++ a ++ b ++ ab
S. Enteritidis 048PP2016 2016 + b + a + a
S. Enteritidis 049PP2016 2016 ++ a +++ b + c
S. Enteritidis 050PP2016 2016 ++ a + a + b
S. Enteritidis 051PP2016 2016 +++ +++ +++
S. Enteritidis 53A 2013 ++ a + b ++ a
S. Enteritidis Korczak 28A 2013 ++ a + b ++ a
S. Enteritidis Korczak 32A 2013 + + +
S. Enteritidis Korczak 40A 2013 ++ a + b + c
S. Enteritidis Korczak 41A 2013 ++ a + b ++ a
S. Enteritidis 4050/2014 D09 2014 ++ a ++ b ++ ab
S. Enteritidis 6537/1/S/14 D09 2014 + a + b + ab
S. Enteritidis 6670/1/S/14 D09 2014 + a + a + b
S. Enteritidis 7660/1/D03 2014 + a + b + c
S. Enteritidis 65/S/10 2010 + a + ab + b
S. Enteritidis 1KSFA 2013 ++ a + ab + b
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To assess their potential as successful probiotics, cer-
tain features that allow them to withstand harsh gas-
trointestinal tract conditions and colonize the intestine 
were examined. Additionally, taking into account their 
potential application in controlling Salmonella sp. in 
poultry farming, the antagonistic activity towards envi-
ronmental poultry isolates of Salmonella sp. bacteria 
and antibiotic susceptibility were evaluated.
The survival of bacteria in the gastrointestinal tract 
is highly dependent on bacteria’s resistance to bile salts 
and low pH (Verdenelli et al. 2009). The tolerance of 
probiotics strains to increased bile salts concentration is 
one of the crucial features responsible for their function 
and stability in the small intestine. Moreover, the high 
concentration of bile salt can be used as a strong tool 
for the selection of potential probiotic strains. In this 
study, all three strains survive under bile salts condi-
tions higher than those observed in the intestinal tract 
(1% and 2%) even after 4 h of incubation. Moreover, 
L. rhamnosus LOCK 1131 strain showed better toler-
ance to the higher bile salt concentration. These results 
are consistent with those of Duary et al. (2012) and 
Wang et al. (2010) who also reported that the potential 
probiotic strains were able to survive at bile salt con-
centration higher than physiological levels. Our find-
ing suggests that the selected Lactobacillus strains have 
the potential to survive in the harsh condition of the 
gastrointestinal tract.
In the case of pH tolerance, probiotic’s passage 
through media with low pH is strain-dependent (Beli-
cová et al. 2013). The results of our study also confirmed 
this observation. L. rhamnosus LOCK 1131 and L. casei 
LOCK 1132 demonstrated very high survival during the 
incubation in the media with pH of 2.0 and 3.0 whereas 
L. paracasei LOCK 1133 cell viability decreased signifi-
cantly at pH 2.0.
To colonize GIT, probiotic bacteria need to adhere 
to mucosal surfaces (Tropcheva et al. 2011). It is a multi-
step process based on non-specific physical interactions 
between cells and bacteria, which then enable specific 
interactions between complementary receptors (Kos 
et al. 2003). Aggregation is the process of reversible 
gathering of bacterial cells belonging to the same bac-
terial strain (autoaggregation) or two different bacte-
rial strains (coaggregation). Adhesion is dependent on 
autoaggregation properties of bacteria, while coaggre-
gation provides close interaction with pathogenic bac-
teria, in which lactobacilli could release antimicrobial 
substances in very close proximity. These features also 
allow probiotics to form a barrier preventing pathogens 
from colonization (Kos et al. 2003; Janković et al. 2012). 
All LAB strains tested showed a high autoaggregation 
rate above 93% observed after 24 h. The coaggregation 
rate with Salmonella sp. was strain-dependent and each 
lactobacilli had different coaggregation rates depend-
ing on the Salmonella strain examined. The highest 
coaggregation was observed for a pair of L. rhamnosus 
LOCK 1131 and S. Typhimurium ATCC 13311 (84%), 
while the lowest for a pair of L. casei LOCK 1132 and 
S. Typhimurium ATCC 14028 (–11%).
One of the most essential features of probiotics is 
their ability to adhere to intestinal cells and colonize 
the gastrointestinal tract of the host. Colonization is 
related to many beneficial effects such as the stimula-
tion of immune system and the prevention of patho-
gen colonization either by probiotics antagonistic 
activity towards pathogens or by their competition for 
a  limited number of receptors on the surface of GIT 
(Cukrowska et al. 2009; Ostad et al. 2009; Verdenelli 
et al. 2009). Thus, a high rate of adherence to the biotic 
surface is the desired feature, whereas adherence to 
the abiotic surface can be problematic in the produc-
tion of a probiotic formulation. Adherence properties 
of lactic acid bacteria depend on many factors – espe-
cially on the cell wall structure and the individual 
strain. In this study, the ability of bacteria to form a bio-
film on an abiotic surface was examined by measur-
ing the adherence to a polystyrene surface. All strains 
revealed weak adherence properties with the adherence 
values ranging from 1.18 ± 0.02 to 1.22 ± 0.02 at 630 nm. 
Adherence to epithelial cells was assessed by measur-
ing the adherence index of LAB strains to Caco-2 cells. 
The highest level of adherence was observed for L. casei 
LOCK 1132 (98.0%) and the weakest adherence of all 
tested strains (78.9%) had L. paracasei LOCK 1133. 
However, all strains strongly adhered to Caco-2 cells 
which was confirmed by microscopic observations 
(results not shown).
Another important method, used in this study, was 
a competition test conducted to observe the stimulation 
or inhibition of Salmonella sp. adherence to Caco-2 cells. 
By adhering to the biotic surface, the probiotics may 
prevent the colonization of pathogenic bacteria. It was 
found that L. casei LOCK 1132 inhibited S. Enteritidis 
ATCC 13076 and S. Typhimurium ATCC 14028, up to 
3.4% and 7.9%, respectively. L. rhamnosus LOCK 1131 
weakly reduced adherence of S. Typhimurium ATCC 
13311 (1%), while L. paracasei LOCK 1133 stimulated 
adherence of all tested Salmonella sp. strains (5 to 10%). 
The inhibition of Salmonella sp. adherence determined 
in this study is not very high when compared to the 
results obtained by others (Jankowska et al. 2008). How-
ever, to gain deeper insight into this phenomenon one 
can consider that the adherence of the pathogens in vivo 
can be interrupted not only by the competition for the 
cell receptors but also by the secretion of antimicrobial 
compounds by the probiotic strains. Further tests are 
necessary to confirm these findings.
To assess the cytotoxicity of probiotic’s metabolic 
products and, thus, to confirm their safety for the 
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application, the NRU assay was performed. No signi-
ficant cytotoxic effect was detected when compared 
to control samples. The undiluted supernatant from 
L. rhamnosus LOCK 1131 culture had the highest cyto-
toxic effect (8%), whereas eight-times diluted superna-
tant from L. paracasei LOCK 1133 culture had lower 
cytotoxic effect than control sample (–18%).
As the target application of the described LAB 
strains for using in poultry farming their susceptibility 
to antibiotics (penicillin G, tetracycline, erythromycin, 
and doxycycline) was evaluated. All three strains were 
found to be resistant to amoxicillin and kanamycin, 
which is not a rare phenomenon among probiotics 
as they are naturally resistant to certain antibiotics. 
Several studies reported lactobacilli intrinsic resist-
ance to kanamycin and amoxicillin (Varankovich et al. 
2015; Imperial and Ibana 2016; Wang et al. 2018). 
In some cases, antibiotic resistance of probiotics could 
be beneficial due to the accompanying administration 
of various antimicrobials during animal farming or the 
application of antibiotic-probiotic combination treat-
ment (Wright et al. 2015). What is more important, the 
probiotic strains identified in our study belong to spe-
cies included in the EFSA QPS list.
Finally, the broad antagonistic spectrum against Sal­
monella sp. was examined as the most desired feature of 
tested LAB strains. The antagonistic activity of probio-
tics towards pathogenic bacteria, could prevent their 
attachment to the gastrointestinal tract and stimulate 
their removal from the intestine (Gaggìa et al. 2010; 
Varankovich et al. 2015; Mokoena 2017).
All tested LAB bacteria revealed the ability to inhibit 
the growth of most of the environmental strains of 
Salmonella sp. and all reference strains. L. rhamnosus 
LOCK 1131 inhibited growth of 125 out of 126 tested 
strains (99.2% coverage), L. casei LOCK 1132 had 98% 
coverage and L. paracasei LOCK 1133 had 96% coverage.
While acting in the gastrointestinal tract, probiotic 
formulations affect an entire body of the animal. It is 
known that lactic acid bacteria compete for food and 
the place of adhesion to the intestinal epithelium with 
pathogens; however, the mechanisms of this actions 
are still not fully understood (Trzeciak et al. 2016). 
Probiotic mixtures seem to have a better effect than 
single bacteria preparation because they can address 
a wide spectrum of pathogens and may have synergistic 
adhesion effects (Verdenelli et al. 2009; Chapman et al. 
2011). The synergistic effect on adhesion and antagonis-
tic activity of presented bacteria still need to be evalu-
ated. There is also the requirement for further research 
that will investigate other properties of studied bacteria 
such as the presence of antibiotic resistance plasmids, 
the nature of the antimicrobial agents produced by 
the bacteria, and the ability to withstand conditions 
of simulated gastrointestinal tract.
Our results showed that L. rhamnosus LOCK 1131, 
L. casei LOCK 1132 and L. paracasei LOCK 1133 possess 
a number of interesting properties and can be consid-
ered as a component of functional feed. They can with-
stand the gut conditions, interact with the host system 
and their safety was proved in the cytotoxicity test. How-
ever, what is most important, they possess antagonis-
tic activity towards a wide spectrum of environmental 
Salmonella species. The S. Enteritidis collection used in 
this study is an epidemiologically representative group 
of strains isolated from poultry in 2009–2016 that were 
confirmed as genetically different (Zaczek et al. 2015). 
Results of antagonistic activity obtained on such repre-
sentative collection of Salmonella sp. allow the conclu-
sion that the probiotics tested in this study have a high 
potential for use in commercial poultry farming.
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